Dr. Anita Goel, M.D., Ph.D., Nanobiosym Chairman and CEO, Wins Galactic Grant to Fund Gene-RADAR® Research in Space

Business News
Print
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nanobiosym®, a global nanotechnology firm, today announced that its Chairman and CEO, Dr. Anita Goel, M.D., Ph.D, has been awarded the top prize in the Galactic Grant Competition to fund the Nanobiosym Research Institute to push the frontier of nanobiophysics and the Gene-RADAR® technology on the International Space Station (ISS), U.S. National Laboratory. Uniquely trained as both a physicist and medical doctor at Stanford, Harvard, and MIT, Dr. Goel has, over

imageimage
image

Read more